PCN9 ERLOTINIB IN NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY–A COST-SAVING SECOND-LINE TREATMENT OPTION?
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63439-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63439-0/fulltext
Title :
PCN9 ERLOTINIB IN NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY–A COST-SAVING SECOND-LINE TREATMENT OPTION?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63439-0&doi=10.1016/S1098-3015(10)63439-0
First page :
Section Title :
Open access? :
No
Section Order :
290